News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
270,487 Results
Type
Article (15040)
Company Profile (304)
Press Release (255143)
Section
Business (80895)
Career Advice (163)
Deals (13422)
Drug Delivery (35)
Drug Development (51469)
Employer Resources (31)
FDA (5973)
Job Trends (5294)
News (147396)
Policy (10295)
Tag
Academia (998)
Alliances (22264)
Alzheimer's disease (814)
Approvals (5956)
Artificial intelligence (74)
Bankruptcy (99)
Best Places to Work (4688)
Biotechnology (249)
Breast cancer (116)
Cancer (925)
Cardiovascular disease (73)
Career advice (143)
CAR-T (73)
Cell therapy (219)
Clinical research (41048)
Collaboration (317)
Compensation (129)
COVID-19 (1057)
C-suite (80)
Cystic fibrosis (67)
Data (1012)
Diabetes (88)
Diagnostics (1777)
Drug discovery (57)
Earnings (29456)
Events (48188)
Executive appointments (250)
FDA (6356)
Funding (311)
Gene editing (64)
Gene therapy (163)
GLP-1 (317)
Government (1104)
Healthcare (6815)
Infectious disease (1096)
Inflammatory bowel disease (100)
IPO (7278)
Job creations (876)
Job search strategy (137)
Layoffs (189)
Legal (1404)
Lung cancer (135)
Lymphoma (63)
Manufacturing (88)
Medical device (2686)
Medtech (2687)
Mergers & acquisitions (6282)
Metabolic disorders (267)
Neuroscience (1062)
NextGen Class of 2024 (2047)
Non-profit (908)
Northern California (1111)
Obesity (145)
Opinion (93)
Parkinson's disease (78)
Patents (64)
People (25376)
Phase I (14402)
Phase II (19091)
Phase III (12082)
Pipeline (368)
Postmarket research (903)
Preclinical (6078)
Radiopharmaceuticals (206)
Rare diseases (207)
Real estate (1436)
Regulatory (8516)
Research institute (1001)
Southern California (1002)
Startups (1988)
United States (8847)
Vaccines (171)
Weight loss (86)
Date
Today (77)
Last 7 days (358)
Last 30 days (1471)
Last 365 days (20981)
2024 (20893)
2023 (22867)
2022 (27487)
2021 (28529)
2020 (24036)
2019 (16762)
2018 (12132)
2017 (14226)
2016 (12351)
2015 (14863)
2014 (10791)
2013 (7841)
2012 (7891)
2011 (7977)
2010 (7776)
Location
Africa (160)
Asia (17396)
Australia (3048)
California (2528)
Canada (826)
China (205)
Colorado (94)
Connecticut (107)
Europe (37934)
Florida (278)
Georgia (71)
Illinois (156)
Indiana (67)
Maryland (337)
Massachusetts (1990)
Michigan (58)
Minnesota (102)
New Jersey (639)
New York (694)
North Carolina (422)
Northern California (1111)
Ohio (82)
Pennsylvania (485)
South America (230)
Southern California (1002)
Texas (284)
Washington State (254)
270,487 Results for "marker therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Marker Therapeutics Provides a Clinical Update on MT-601 in Patients with Lymphoma
December 20, 2024
·
8 min read
Press Releases
Marker Therapeutics to Present at the Citizens JMP Hematology and Oncology Summit
November 26, 2024
·
3 min read
Press Releases
Marker Therapeutics to Present at the 2024 Ladenburg Thalmann & Co. Virtual Oncology Innovators and Investors Symposium
December 10, 2024
·
3 min read
Press Releases
Marker Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Updates
November 14, 2024
·
10 min read
Business
Marker Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates
Marker Therapeutics, Inc. (Nasdaq: MRKR), a clinical-stage immuno-oncology company focusing on developing next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumors, today reported corporate updates and financial results for the first quarter ended March 31, 2024.
May 15, 2024
·
12 min read
Lone Star Bio
Marker Therapeutics to Present at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference
Marker Therapeutics, Inc. (Nasdaq: MRKR) today announced that Juan Vera, M.D., President and Chief Executive Officer of Marker Therapeutics, will present at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference.
March 22, 2024
·
3 min read
Press Releases
Marker Therapeutics Awarded $9.5 Million Grant from the Cancer Prevention & Research Institute of Texas (CPRIT) to Support the Investigation of MT-601 in Patients with Pancreatic Cancer
December 18, 2024
·
7 min read
Business
Marker Therapeutics Reports Year-End 2023 Corporate and Financial Results
Marker Therapeutics, Inc. (Nasdaq: MRKR), a clinical-stage immuno-oncology company focusing on developing next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumors, today reported recent corporate developments and financial results for the year ended December 31, 2023.
March 25, 2024
·
14 min read
Lone Star Bio
Marker Therapeutics Announces Clinical Program Updates and Pipeline Prioritization
Marker Therapeutics, Inc. today announced a restructuring of its clinical programs and a strategic prioritization of its multi-tumor associated antigen (multiTAA)-specific T cell product pipeline.
January 8, 2024
·
11 min read
Press Releases
Marker Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Updates
August 15, 2024
·
11 min read
1 of 27,049
Next
